Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masami Murakami

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
Journal of Clinical Lipidology|July 2, 2017
GPIHBP1 autoantibodies in a patient with unexplained chylomicronemiaXuchen Hu, Geesje M Dallinga-Thie, G Kees Hovingh, et al.
Journal of Clinical Lipidology|September 6, 2022
GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitisGuofu Zhang, Qi Yang, Wenjian Mao, et al.
Journal of Clinical Lipidology|December 6, 2018
GPIHBP1 autoantibody syndrome during interferon β1a treatmentJun Eguchi, Kazuya Miyashita, Isamu Fukamachi, et al.
Journal of Clinical Lipidology|July 8, 2026
Successful long-term remission of hyperchylomicronemia caused by GPIHBP1 autoantibodies: With insights into antibody epitope effectsAyano Yamaguchi, Naoya Teramoto, Suzuka Watanabe, et al.
Clinical Chemistry|February 3, 2009
Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2Tohru Aomori, Koujirou Yamamoto, Atsuko Oguchi-Katayama, et al.
Biomedical Reports|July 24, 2014
Single-nucleotide polymorphism (c.309T>G) in the <i>MDM2</i> gene and lung cancer riskYasuaki Enokida, Kimihiro Shimizu, Seiichi Kakegawa, et al.
Journal of Lipid Research|November 23, 2016
Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPLXuchen Hu, Mark W Sleeman, Kazuya Miyashita, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2019
Lipoprotein lipase is active as a monomerAnne P Beigneux, Christopher M Allan, Norma P Sandoval, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2023
The lipoprotein lipase that is shuttled into capillaries by GPIHBP1 enters the glycocalyx where it mediates lipoprotein processingWenxin Song, Anne P Beigneux, Thomas A Weston, et al.
Plos One|November 19, 2013
A critical role of fatty acid binding protein 4 and 5 (FABP4/5) in the systemic response to fastingMas Rizky A A Syamsunarno, Tatsuya Iso, Hirofumi Hanaoka, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Journal of Clinical Lipidology|July 2, 2017
GPIHBP1 autoantibodies in a patient with unexplained chylomicronemiaXuchen Hu, Geesje M Dallinga-Thie, G Kees Hovingh, et al.
Journal of Clinical Lipidology|September 6, 2022
GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitisGuofu Zhang, Qi Yang, Wenjian Mao, et al.
Journal of Clinical Lipidology|December 6, 2018
GPIHBP1 autoantibody syndrome during interferon β1a treatmentJun Eguchi, Kazuya Miyashita, Isamu Fukamachi, et al.
Journal of Clinical Lipidology|July 8, 2026
Successful long-term remission of hyperchylomicronemia caused by GPIHBP1 autoantibodies: With insights into antibody epitope effectsAyano Yamaguchi, Naoya Teramoto, Suzuka Watanabe, et al.
Clinical Chemistry|February 3, 2009
Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2Tohru Aomori, Koujirou Yamamoto, Atsuko Oguchi-Katayama, et al.
Biomedical Reports|July 24, 2014
Single-nucleotide polymorphism (c.309T>G) in the <i>MDM2</i> gene and lung cancer riskYasuaki Enokida, Kimihiro Shimizu, Seiichi Kakegawa, et al.
Journal of Lipid Research|November 23, 2016
Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPLXuchen Hu, Mark W Sleeman, Kazuya Miyashita, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2019
Lipoprotein lipase is active as a monomerAnne P Beigneux, Christopher M Allan, Norma P Sandoval, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2023
The lipoprotein lipase that is shuttled into capillaries by GPIHBP1 enters the glycocalyx where it mediates lipoprotein processingWenxin Song, Anne P Beigneux, Thomas A Weston, et al.
Plos One|November 19, 2013
A critical role of fatty acid binding protein 4 and 5 (FABP4/5) in the systemic response to fastingMas Rizky A A Syamsunarno, Tatsuya Iso, Hirofumi Hanaoka, et al.
Pageof 20